Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alejandro Lazo-Langner

Showing results (121-130 of 135) with videos related to

Pageof 14
Sort By:
BMJ (Clinical Research Ed.)|June 10, 2021
Postoperative low molecular weight heparin bridging treatment for patients at high risk of arterial thromboembolism (PERIOP2): double blind randomised controlled trialMichael J Kovacs, Philip S Wells, David R Anderson, et al.
Current Oncology (Toronto, Ont.)|April 26, 2024
Myelodysplastic Neoplasms (MDS) with Ring Sideroblasts or <i>SF3B1</i> Mutations: The Improved Clinical Utility of World Health Organization and International Consensus Classification 2022 Definitions, a Single-Centre Retrospective Chart ReviewShamim Mortuza, Benjamin Chin-Yee, Tyler E James, et al.
CMAJ Open|July 19, 2022
Clinical characteristics, multiorgan dysfunction and outcomes of patients with COVID-19: a prospective case seriesKimia Honarmand, Kyle Fiorini, Debarati Chakraborty, et al.
British Journal of Haematology|June 27, 2020
Clinical value of next-generation sequencing compared to cytogenetics in patients with suspected myelodysplastic syndromeEri Kawata, Alejandro Lazo-Langner, Anargyros Xenocostas, et al.
International Journal of Laboratory Hematology|October 29, 2021
Reducing cytogenetic testing in the era of next generation sequencing: Are we choosing wisely?Eri Kawata, Benjamin D Hedley, Benjamin Chin-Yee, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 9, 2024
Serologic Response to Vaccine for COVID-19 in Patients with Hematologic Malignancy: A Prospective Cohort StudyAlexandra Hillyer, Anthony Quint, Artin Ghassemian, et al.
The New England Journal of Medicine|November 28, 2019
Diagnosis of Pulmonary Embolism with d-Dimer Adjusted to Clinical ProbabilityClive Kearon, Kerstin de Wit, Sameer Parpia, et al.
Blood|July 5, 2011
Prospective evaluation of a pharmacogenetics-guided warfarin loading and maintenance dose regimen for initiation of therapyInna Y Gong, Rommel G Tirona, Ute I Schwarz, et al.
The New England Journal of Medicine|June 23, 2015
Screening for Occult Cancer in Unprovoked Venous ThromboembolismMarc Carrier, Alejandro Lazo-Langner, Sudeep Shivakumar, et al.
Blood Advances|June 9, 2022
Predicting major bleeding during extended anticoagulation for unprovoked or weakly provoked venous thromboembolismPhilip S Wells, Tobias Tritschler, Faizan Khan, et al.
Pageof 14

Showing results (121-130 of 135) with videos related to

Sort By:
Pageof 14
BMJ (Clinical Research Ed.)|June 10, 2021
Postoperative low molecular weight heparin bridging treatment for patients at high risk of arterial thromboembolism (PERIOP2): double blind randomised controlled trialMichael J Kovacs, Philip S Wells, David R Anderson, et al.
Current Oncology (Toronto, Ont.)|April 26, 2024
Myelodysplastic Neoplasms (MDS) with Ring Sideroblasts or <i>SF3B1</i> Mutations: The Improved Clinical Utility of World Health Organization and International Consensus Classification 2022 Definitions, a Single-Centre Retrospective Chart ReviewShamim Mortuza, Benjamin Chin-Yee, Tyler E James, et al.
CMAJ Open|July 19, 2022
Clinical characteristics, multiorgan dysfunction and outcomes of patients with COVID-19: a prospective case seriesKimia Honarmand, Kyle Fiorini, Debarati Chakraborty, et al.
British Journal of Haematology|June 27, 2020
Clinical value of next-generation sequencing compared to cytogenetics in patients with suspected myelodysplastic syndromeEri Kawata, Alejandro Lazo-Langner, Anargyros Xenocostas, et al.
International Journal of Laboratory Hematology|October 29, 2021
Reducing cytogenetic testing in the era of next generation sequencing: Are we choosing wisely?Eri Kawata, Benjamin D Hedley, Benjamin Chin-Yee, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 9, 2024
Serologic Response to Vaccine for COVID-19 in Patients with Hematologic Malignancy: A Prospective Cohort StudyAlexandra Hillyer, Anthony Quint, Artin Ghassemian, et al.
The New England Journal of Medicine|November 28, 2019
Diagnosis of Pulmonary Embolism with d-Dimer Adjusted to Clinical ProbabilityClive Kearon, Kerstin de Wit, Sameer Parpia, et al.
Blood|July 5, 2011
Prospective evaluation of a pharmacogenetics-guided warfarin loading and maintenance dose regimen for initiation of therapyInna Y Gong, Rommel G Tirona, Ute I Schwarz, et al.
The New England Journal of Medicine|June 23, 2015
Screening for Occult Cancer in Unprovoked Venous ThromboembolismMarc Carrier, Alejandro Lazo-Langner, Sudeep Shivakumar, et al.
Blood Advances|June 9, 2022
Predicting major bleeding during extended anticoagulation for unprovoked or weakly provoked venous thromboembolismPhilip S Wells, Tobias Tritschler, Faizan Khan, et al.
Pageof 14